Purpose It is unclear whether adding concurrent chemotherapy (CT) to definitive
radiotherapy (RT) following induction CT is a tolerable and cost effective treatment for non …

Introduction Elderly patients account for the majority of lung cancer diagnoses but are poorly
represented in clinical trials. We evaluated the overall survival (OS) of elderly patients with …

In stage III non-small cell lung cancer (NSCLC), the standard of care in young patients is
chemoradiotherapy, but this standard is not as clearly established for older patients. We …

Radiotherapy (RT) is the standard therapy for unresected stage I–II nonsmall cell lung
cancer (NSCLC). Using population-based data, we compared survival and toxicity among …

Background Elderly patients with non-small cell lung cancer (NSCLC) are frequently treated
with radiation therapy (RT) alone, due to poor performance status or underlying disease. We …

Introduction Optimal treatment for older adults with stage III non-small cell lung cancer
(NSCLC) remains unclear. Here we hypothesized that sequential chemoradiation therapy …

Background and purpose Combined chemoradiotherapy (CRT) is considered the standard
care for unresectable stage III non-small cell lung cancer (NSCLC). There have been limited …

Background Elderly patients are underrepresented in trials that establish definitive
chemoradiotherapy as the standard of care for inoperable stage III non–small-cell lung …

Purpose Chemoradiotherapy is the standard of care for unresectable stage III non-small cell
lung cancer (NSCLC). Elderly patients, who are often considered unfit for combined …

Background Standard treatment for stage III non–small-cell lung cancer (NSCLC) is
concurrent chemotherapy and radiation (chemo-RT). However, N3 stage IIIB disease …